Our IC3D® platform has been engineered to deliver enrichment-free analytical results in minutes for testing of pathogenic agents, such as bacteria, viruses, genes, and cancer biomarkers. In addition to the high-sensitivity, our system has been designed to process crude samples eliminating the laborious steps involved in traditional biochemical analysis such as centrifugation, pipetting, and filtration. Our technology has the potential to improve patient outcomes by providing healthcare professionals with the most relevant and accurate information quickly. The result of which is reduced healthcare costs and lowered patient re-visits.
Integrated Comprehensive Droplet Digital Detection - IC 3D®
High morbidity and mortality associated with pathogenic agents, such as multidrug-resistant bacteria, are due, in part, to the inability of healthcare professionals to rapidly detect, treat, and monitor patient health at the early stages of infection. At present, most detection platforms are limited by design because they require target enrichment periods, such as culturing, to bring target levels to detectable thresholds. Many of these systems rely on signal amplification systems, such as PCR, to reliably measure signal output. Combined, these systems require extensive incubation, processing, and data analysis periods that can last days and weeks putting the patient at greater risk when they are weakest and most vulnerable.